Global Live Cell Imaging Market

Live Cell Imaging Market Insights

The live-cell imaging market is estimated to grow upwardly during the forecast period. The technique of live cell imaging provides scientists with an effective tool to study cells, their structures, processes, and features in real-time. The technique has brought a revolution in the study of molecular interactions, cells, proteins, and varied processes. The live-cell technique is more reliable than fixed cell imaging due to its less vulnerability to experimental artifacts giving the market for live cell imaging a concrete foundation to grow. The advancements in microscopic imaging platform technology, also potential developments in optical biosensors and image analysis have led to the fast deployment of live cell imaging in novel drug discovery. These rapid advances put the market on a more competitive path during the forecast period. The COVID-19 virus will positively impact the market as more research would be inclined towards how the virus affects the cell and its composition.

Live Cell Imaging Market: By Products & Services

Based on the products & services, the market considers software, consumables, instruments, and services into being. The software category would be an important determinant in the high growth of the live cell imaging market. Studying the cell cycle,  the impact of compounds on the progression of the cell cycle is tedious work. The modular software helps to the establishment of the image analysis workflows and also fastens the process effectively leading to high segment growth. The instruments used in the technique would also be the fastest-growing category owing to the rapid investment and advances in fluorescent microscopy and protein technology.

Live Cell Imaging Market: By Application

The application category tends to include cell biology, stem cells, and drug discovery among others. The stem cell application segment would be growing fastest in the market owing to the diverse range of tools developed by manufacturers in the market space. With Nanolive label-free live-cell imaging, it is possible to observe and study stem cells in 3D that too over long periods.

Live Cell Imaging Market: By Technology

The technology used in the market includes time-lapse microscopy, fluorescence recovery after photobleaching, and high content screening among others. The time-lapse microscopy technology is rapidly advancing and will show an upward rising trend during the forecast period.  The technique has improved and developed to study the cellular processes and is also implied in molecular aspects, medical practice, and cell biology. The technique holds promise for medicine and biological science. Such varied applications lead to better growth of technology in the market.

Live Cell Imaging Market: By End User

Based on the end-user, the market comprises pharmaceutical & biotechnology, academic & research institutes, and contract research organizations. The pharmaceutical &biotechnology would register the fastest growth in the market for live-cell imaging. The segment is growing owing to fast novel drug discoveries and increased R &D activities.

Live Cell Imaging Market: By Region

Based on the geographical analysis, Asia Pacific is believed to be the leading player in this market domain. The growing interest in stem cell research in the region, already established labs and research institutes and prioritizing the research and development activities in the live cell imaging technique push the region’s potential towards the greater edge, leading for the market to grow in the region.

Market Share and Competitive Analysis

Key players operating in the market include Bio-Rad, BioTek Instruments, Cytiva, Blue-Ray Biotech, CytoSMART Technologies, Curiosis, Carl Zeiss Microscopy, GE Healthcare Life Sciences, Leica Microsystems, Thermo Fisher Scientific, Perkin Elmer, Danaher Corporation, Bruker Corporation, Nikon Corporation, and Olympus Corporation among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In September 2019, BioTel Instruments was acquired by Agilent Technologies, to enable Agilent Technologies to expand its presence in cell analysis.

Check the Press Release on Global Live Cell Imaging Market Report